Androgenic functions lead to the development of a male phenotype during gestation of the mammalian XY embryo, in addition to the secondary sexual characteristics that appear after puberty in an individual [Dohle et al., 2003] . Androgen hormones elicit their effects on target cells by binding to a cytosolic androgen receptor (AR) that is a member of the nuclear receptor superfamily [Brinkmann et al., 1989] . The AR protein then acts as a transcription factor at sites of the androgen response DNA elements [Koochekpour, 2010] . A recent study identified hundreds of AR target genes by transcriptome analysis of AR knockout mice, demonstrating a wide variety of functions regulated by the AR in Sertoli cells [De Gendt et al., 2014] . The receptor itself is encoded by the AR gene, a 186-kb DNA region on the human X chromosome that contains 8 exons and translates into a 99-kD protein. These exons code for 3 specific and conserved regions of the receptor across mammalian species [Brinkmann et al., 1989; Jääskeläinen, 2012] . Exon 1, when translated, is implicated in the regulation of AR functions through the presence of multiple phosphorylation and co-activator binding sites. Moreover, exons 2-3 encode
Androgenic functions lead to the development of a male phenotype during gestation of the mammalian XY embryo, in addition to the secondary sexual characteristics that appear after puberty in an individual [Dohle et al., 2003] . Androgen hormones elicit their effects on target cells by binding to a cytosolic androgen receptor (AR) that is a member of the nuclear receptor superfamily [Brinkmann et al., 1989] . The AR protein then acts as a transcription factor at sites of the androgen response DNA elements [Koochekpour, 2010] . A recent study identified hundreds of AR target genes by transcriptome analysis of AR knockout mice, demonstrating a wide variety of functions regulated by the AR in Sertoli cells [De Gendt et al., 2014] . The receptor itself is encoded by the AR gene, a 186-kb DNA region on the human X chromosome that contains 8 exons and translates into a 99-kD protein. These exons code for 3 specific and conserved regions of the receptor across mammalian species [Brinkmann et al., 1989; Jääskeläinen, 2012] . Exon 1, when translated, is implicated in the regulation of AR functions through the presence of multiple phosphorylation and co-activator binding sites. Moreover, exons 2-3 encode the DNA-binding domain (DBD), which contains a zinc finger dimer responsible for DNA binding and specificity. The remaining exons 4-8 translate into the region responsible for the ligand-binding domain (LBD), a hingelike region that links the LBD to the DBD and provides more regulatory control as well as translocation and transactivation capabilities of the receptor protein [Brinkmann et al., 1989; Jääskeläinen, 2012] .
When the function of the AR is impaired, several different conditions may result [Singh et al., 2007] . The most noteworthy of these conditions is the spectrum of the socalled androgen insensitivity syndrome (AIS), as well as its association with neoplastic diseases including prostate and testicular cancers [Holterhus et al., 2005] . In humans, the AR gene mutation database (http://androgendb.mcgill.ca) [Gottlieb et al., 2012] records over 1,100 known mutations resulting in varying degrees of AIS or other conditions. Currently, AIS is classified as a disorder of sex development (DSD) and occurs when the AR is unable to produce the downstream transcriptional regulatory effects, or alternatively when these effects are insufficient to lead to a normal male phenotype. This could result in XY individuals with underdeveloped masculine features such as a micropenis in the case of partial androgen insensitivity or XY individuals with a female phenotype in the case of complete androgen insensitivity [Holterhus et al., 2005; Hughes et al., 2012] . The frequencies of these conditions in humans are reported at 1: 20,000 to 1: 99,000 for those identified genetically as males [Oakes et al., 2008; Mazen et al., 2010] .
Intersexuality has been reported in a wide array of domestic animal species including dogs, buffalo, and horses [Howden, 2004; Iannuzzi et al., 2004; Villagómez et al., 2009a; Poth et al., 2010] . The first molecular link between a 64,XY DSD condition and the AR was documented by Révay et al. [2012] , who identified a start codon mutation in the AR gene of an American Quarter Horse pedigree that resulted in complete androgen insensitivity for 3 members of the horse family.
Here, we report on the findings of a novel equine AR mutation that segregates amongst closely related family members of the Thoroughbred breed.
Materials and Methods

Clinical Description of the Proband
A 4-year-old Thoroughbred mare that showed elevated urinary testosterone levels during routine in-competition testing by the South African National Horseracing Authority Laboratory in Johannesburg was presented to the Onderstepoort Veterinary Academic Hospital, University of Pretoria for gender verification. Externally, the horse resembled a mare with a normal vulva and perineum. Manual eversion of the clitoris revealed this structure to be normal. The udder was non-lactating and appeared normal on inspection and palpation. On vaginoscopy, the vagina was found to be blind, ending with no apparent cervix. Transrectal palpation failed to identify tubular structures consistent with either a uterus or a cervix. An ovoid structure, approximately 8 × 5 × 4 cm in size, with a smooth profile and without an obvious ovulation fossa, was palpated in the region approximating to the expected site of the left ovary. Transrectal and transabdominal ultrasound (SonoScape A5V, SonoScape Co. Ltd., Shenzhen, China) of this structure was performed using both a 7.5-mHz linear array and a 5-mHz curvilinear transducer, respectively. The structure was found to be homogeneously echogenic with a central core of increased echogenicity, ultrasonographically resembling a cryptorchid testis. Neither an epididymis nor features typical of ovarian structures were identified. A second structure of approximately 6 × 6 × 4 cm located dorsally in the abdominal cavity, to the right of the midline and just cranial to the pelvic inlet, was identified on further transrectal examination. This structure's palpable and ultrasonographic features similarly resembled a cryptorchid testis. Fig. 1 . Pedigree of the investigated Thoroughbred horse family. The proband DSD is marked with an arrow, and the asterisks denote animals tested with PCR-RFLP only. The causative exon 4 mutation genotypes are marked for each sequenced animals.
The horse was challenged with an intravenously administered bolus of 6,000 IU human chorionic gonadotrophin (hCG) (Chorulon, Zoetis, South Africa), a luteinizing hormone (LH) analog, to observe potential testosterone production by radioimmunoassay (#PITKTT-8, Coat-A-Count Testosterone, Diagnostic Product Corporation, Los Angeles, Calif., USA) [Cox et al., 1973] . Serial serum samples, including a pre-treatment sample, were collected by jugular venipuncture. The pre-treatment serum testosterone level was 3,576.37 pg/ml (reference values for a mature, intact stallion are 800-2,000 pg/ml). Testosterone levels remained high after hCG administration: 30 min (3,554.67 pg/ml), 4 h (3,478.39 pg/ ml), and 24 h (3,778.10 pg/ml).
At the owner's request, bilateral gonadectomy via standing flank laparoscopy was performed as previously described [RubioMartínez, 2012] . The excised gonads macroscopically resembled testes. Histopathology of these structures revealed hypoplastic seminiferous tubules containing Sertoli cells without germ cells, surrounded by connective tissue containing Leydig cells. No features of ovarian tissue were identified histologically in the sections examined.
Karyotyping performed by Unistel Medical Laboratories, Tygerberg, South Africa, revealed a 64,XY chromosome constitution, consistent with gender assignment as a male. 
Sampling of Additional Pedigree Members
Peripheral blood samples (with EDTA) were drawn from the DSD clinical case along with 8 additional maternal relatives: the dam (CM), a full sister (FC), 2 aunts (AU and CV), 2 half-sisters (CM14 and WS), a female cousin (VS), and a half-brother (HT). The pedigree of the animals, drawn by Pedigree Draw software (Genial Inc.), is represented in figure 1 . An unrelated male and a female were used as controls. All samples underwent DNA extraction using the PrepFiler Forensic DNA Extraction Kit (Thermo Fisher Scientific) as per the manufacturer's instructions [Brevnov et al., 2009] .
Detection of Sex Chromosomes by qPCR
Quantitative polymerase chain reaction (qPCR) was used to determine the presence of X and Y chromosomes in 6 members of the family (CM, AU, DSD, HT, CM14, and WS). Five Y chromosomal genes (SRY, ZFY, EIF1AY, TSPY, USP9Y) and a single copy X chromosomal gene (AR) were amplified in a CFX96 Touch TM Real-Time PCR Detection System (Bio-Rad) under the following thermal profile: 98 ° C, 2 min; 40× (98 ° C, 10 s; 59 ° C, 15 s). A melting curve was then generated between 72 ° C and 95 ° C, in 0.5 ° C/s increments. The 10-μl reaction mix consisted of 1× SsoFast EvaGreen Supermix (Bio-Rad), 2.25 m M primers ( table 1 ) , and 5 ng genomic DNA. Samples were run in triplicate, and runs were repeated twice. Specificity of the amplicons was tested against normal female and male control DNA. The ratio of Y to X chromosome in the proband and a half-sister (DSD and CM14) was also calculated relative to the half-brother (HT) after normalization against the single copy X chromosomal AR reference gene using the efficiency corrected ΔΔCq formula [Pfaffl, 2001] in CFX Manager (Bio-Rad). Amplification efficiency values were calculated by averaging the individual efficiencies using the LinReg software ( table 1 ) [Ramakers et al., 2003] . The one-sample t test was applied to test differences to the expected Y/X ratio value of 1.0 (GraphPad). The specificity of PCR products was tested by 1.5% agarose gel electrophoresis.
AR Gene Sequencing
Primer sets previously designed to anneal at the surrounding introns [Révay et al., 2012] ( table 1 ) were used to sequence all 8 exons of the horse AR gene in 6 pedigree members (CM, AU, DSD, HT, CM14, and WS). Due to the size of exon 1 (1,501 bp), 4 overlapping primer pairs were designed. The PCR mixture was a 20-μl reaction per primer per sample containing 20 ng DNA, 0.5 μ M primers, and 1× Amplitaq Gold 360 master mix (Thermo Fisher Scientific). Amplification was done in an MJ Research PTC-200 Thermo Cycler with the following thermal profile: 95 ° C for 10 min and 30× (94 ° C, 45 s; 59 ° C, 45 s; 72 ° C, 45 s), 72 ° C, 10 min. PCR products were visualized for quality control using gel electrophoresis. Sequencing of the resulting PCR products was conducted using fluorescent dye-terminator cycle sequencing and capillary electrophoresis at the Laboratory Services Division of the University of Guelph. The sequences were checked for quality and aligned to the GenBank horse AR reference sequence (NM_001163891) using Geneious Pro software v.7.1.7 (Geneious Inc). Sequences were deposited to the NCBI GenBank (accession numbers KU158182-158187).
Mutation Identification by PCR-RFLP Analysis
The PCR composed as for the above-mentioned sequencing reaction but using the E4F2-E4R primer pair to amplify a part of exon 4 and intron 4 ( table 1 ). A 5-μl PCR product was digested with 1 μl FastDigest Sau 96I (Cfr13I, Thermo Fisher Scientific) in 1× FastDigest Green Buffer at 37 ° C for 12 min. The results of digestion were visualized by gel electrophoresis.
Results
Sex Chromosome Testing by qPCR qPCR revealed signals from all 5 Y chromosomal genes (SRY, ZFY, EIF1AY
, TSPY, and USP9Y) in HT, DSD, and the control stallion and also identified a XY chromosome constitution in a half-sister (CM14). This animal was a previously unidentified case of XY DSD. The X chromosomal qPCR signal was observed in all samples. The qPCR products were also visualized by gel electrophoresis and revealed single amplicons of the expected product sizes ( fig. 2 ) . The Y/X chromosome ratio was calculated for DSD and CM14 after normalization against the stallion HT to exclude sex chromosome mosaicism and found to be the following for the 4 genes: SRY : 1.09, 0.99; EIF1AY : 1.15, 0.85; USP9Y : 1.12, 0.95; ZFY : 0.84, 1.23 ( fig. 3 ) . None of these values differed statistically from the expected value of 1, thus confirming a normal XY chromosome constitution. The ratio was not calculated for TSPY , as it is a multicopy gene in horses.
AR Gene Sequencing
All 8 exons of the AR gene were sequenced using the primer sets listed in table 1 . Their design ensured full and accurate coverage of the exonic regions and insights into the surrounding introns. We compared the bidirectional sequences of the family members to each other as well as to the horse AR reference sequence (Gene ID: 100033980). Among the ∼ 5,000 bp individual AR sequences generated in 6 members of the family we identified 3 variable positions ( fig. 4 ) . These 3 substitutions occurred in exons 1 and 4, and intron 7. The T allele of the previously described exon 1 c.322C>T transition was observed in all 6 horses, as compared to the reference C allele. The second substitution, a transversion in exon 4 (c.2042G>C), resulted in the TGG codon being changed to TCG, thus encoding for serine instead of the wild-type tryptophan (p.Trp681Ser). Both DSD and CM14 were found to be hemizygous, while the proband's mother and half-sister (CM and WS) were heterozygous carriers, and an additional 2 family members (HT and AU) carried only the wild-type G allele. Another transversion was discovered in the intronic region just downstream of exon 7 (2493+27G>T), with CM being heterozygous, DSD and CM14 hemizygous, and WS homozygous carriers, while HT and AU were both homozygous normal. An independent sequencing run from a second DNA isolate confirmed the genotypes of this latter position.
AR PCR-RFLP Testing
As only the exon 4 (c.2042G>C) mutation segregated in the pedigree according to the phenotypes, a PCR-RFLP test was designed for this locus to provide a simple way of testing further pedigree members. The Cfr13I restriction endonuclease recognizes the GGNCC cleavage sites, thus carriers of the TGG wild-type codon would exhibit a cleavage while the TCG carriers remain uncut. After visualizing the digestion on a 1.5% agarose gel ( fig. 5 ), the expected pattern was observed: the hemizygotes DSD and CM14 displayed 1 uncut PCR product (343 bp). Contrastingly, the 2 wild type HT and AU had 2 bands (230 and 113 bp), whereas the heterozygous carriers CM and WS had 3 bands (113, 230, 343 bp) , showing 1 cut and 1 uncut allele. The 3 additional family members (CV, FC, VS) were found to be wild type.
Discussion
In horses, as in other mammals, sex reversal syndrome refers to cases of DSD where there is discrepancy between the genetic and phenotypic sex of the animal [Villagómez et al., 2009b] . This manifests in a variety of disorders including androgen insensitivity [Holterhus et al., 2005] . Here, a single Thoroughbred DSD horse was observed with typical symptoms of AIS including a female phenotype with a male genotype constitution (XY, SRY+), intra-abdominal hypoplastic testes, lacking spermatogenesis, and elevated serum testosterone levels. Various cases of presumed testicular feminization have been described previously in horses [reviewed by Villagómez et al., 2009b] ; however, most are lacking investigations at the molecular level. The identification of a start codon mutation (c.1A>G) in AR was the first molecular link between the clinical findings and AIS in horses [Révay et al., 2012] . This is the only mutation of the horse AR currently listed in the Online Mendelian Inheritance in Animals database (OMIA 000991-9796). Moreover, this mutation is currently the only one reported for AR in domesticated animals.
The current study described a second SNP variant in AR exon 4 (c.2042G>C) that was postulated as a causative missense mutation. This type of transversion is expected to lead to a radical amino acid substitution where tryptophan would be replaced by serine (p.Trp681Ser). These 2 amino acids are indeed very different in chemical properties and their predicted role in protein structure or function (NCBI Amino Acid Explorer, http://www.ncbi.nlm. nih.gov/Class/Structure/aa/aa_explorer.cgi). Tryptophan contains an indole side chain and is thus the largest, nonpolar, non-charged, hydrophobic amino acid, while serine is small, polar, non-charged, and hydrophilic. Tryptophan is the least plentiful building block in proteins, and its evolutionary stability is among the highest [Grantham, 1974; Miyata et al., 1979] ; thus tryptophan mutations are very rare and carry the highest risk for causing diseases [Vitkup et al., 2003] . Consequently the Trp>Ser replacement is predicted to result in an adverse effect on protein function as reflected by the small or negative values in the various pairwise amino acid substitution matrices [Gonnet et al., 1992; Henikoff and Henikoff, 1992] . The expression of the region of exon 4 where the mutation occurred contributes to the formation of the LBD [Hughes et al., 2012] . This highly complex domain is built from 11 α-helices and 2 β-sheets to form the ligand-binding pocket in which hy- [Gottlieb et al., 2012] with all of them resulting in AIS. Although none of these mutations are actual Trp>Ser substitutions, these examples support our hypothesis that this exon 4 mutation is causative for AIS in the current horse pedigree.
With a candidate causative mutation successfully identified, the secondary objective was to develop a molecular test for identification of potential carriers among additional family members within the affected pedigree. The designed PCR-RFLP test was shown to be a valuable molecular tool for identifying the causative mutation in potential horse carriers. The horse family studied here was drawn from the South African Thoroughbred population. As Thoroughbreds are primarily selected for breeding based on their prior athletic performance, AIS may only be detectable in apparently normal adult mares that persistently fail to show cyclic reproductive activity. Application of PCR-RFLP testing within families related to the identified DSD horses could provide a rapid and affordable method to screen for affected horses. This would prevent the propagation of this mutation and the associated increased costs and management efforts in the international Thoroughbred breeding industry.
Another silent mutation in exon 1 (c.322C>T) described by Révay et al. [2012] in an American Quarter Horse family was also observed in the current study. However, while the 2 alleles (C>T) segregated among the animals in the previous report, all sequenced animals in the current (Thoroughbred) family invariably carried the T allele as homozygous or hemizygous genotypes ( fig. 4 ) , and therefore, the causative status of this SNP was excluded. A third nucleotide substitution was identified in intron 7 (2493+27G>T) that did not segregate according to the DSD phenotype and the observed zygosity status of the exon 4 mutation. Nevertheless, these variants expand the currently limited information available on the population variability of AR in horses.
Our results showed that a previously undescribed missense mutation (c.2042G>C) for the horse AR was causative of familial AIS in the proband Thoroughbred's pedigree. While 64,XY (SRY+) DSD individuals in the family were hemizygous mutation carriers, phenotypically normal horse mares were either heterozygous carriers or homozygous wild types. It was hypothesized that the mutation leads to a substantial change from a large, non-polar, hydrophobic tryptophan to a small, polar, hydrophilic serine, which interferes with the AR protein to interact with its steroid ligands. Additionally, this study outlined a rapid, efficient, and cost-effective molecular test that allows for the identification of this mutation in the Thoroughbred horse population.
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CM AU DSD HT CM14 WS Fig. 5 . PCR-RFLP of AR exon 4. Digestion shows 2 hemizygous mutants (DSD and CM14) with 1 uncut band, 2 heterozygous carriers (CM and WS) with 3 bands (1 uncut and 2 from the digested allele), and 2 homozygous wild-type animals (HT and AU) with 2 bands from the cleavage.
